{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-25-070554","form_type":"8-K","ticker":"OMER","cik":"0001285819","company_name":"OMEROS CORP","filed_at":"2025-07-25T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.584115+00:00","generated_at":"2026-05-18T00:52:41.254440+00:00","sec_items":["8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Omeros prices $22M offering, discloses advanced partnership talks, narsoplimab PDUFA now Dec 2025","bullets":["Sold 5,365,853 shares at $4.10 each to Polar Asset Management; net proceeds ~$20.3M; expected close July 28.","Narsoplimab BLA PDUFA date extended from Sep 25, 2025 to Dec 26, 2025; labeling discussions planned by Oct 2025.","Advanced partnership discussion: potential multi-billion transaction value excl. royalties; upfront would repay $67.1M term loan and $17.1M notes.","Cash and equivalents $26.0M as of July 18; 61.8M shares outstanding.","PDE7 inhibitor program: preclinical studies for cocaine use disorder completed; FDA requests more preclinical info."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-25-070554","json":"https://secwatch.observer/filing/0001104659-25-070554.json","markdown":"https://secwatch.observer/filing/0001104659-25-070554.md","text":"https://secwatch.observer/filing/0001104659-25-070554.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/0001104659-25-070554-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1285819/000110465925070554/tm2516030d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-18T00:52:41.254440+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}